HomeELIC • STO
add
Elicera Therapeutics AB
Previous close
kr 6.36
Day range
kr 5.60 - kr 6.37
Year range
kr 2.05 - kr 8.43
Market cap
304.32M SEK
Avg Volume
179.11K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 30.00K | -98.96% |
Operating expense | 7.16M | 23.81% |
Net income | -6.97M | -167.56% |
Net profit margin | -23.22K | -25,506.46% |
Earnings per share | — | — |
EBITDA | -7.13M | -144.98% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 24.85M | -5.88% |
Total assets | 27.42M | -0.53% |
Total liabilities | 4.06M | -40.26% |
Total equity | 23.36M | — |
Shares outstanding | 48.54M | — |
Price to book | 13.25 | — |
Return on assets | -55.08% | — |
Return on capital | -66.40% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -6.97M | -167.56% |
Cash from operations | -10.08M | -138.11% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -10.08M | -138.11% |
Free cash flow | -7.57M | -119.15% |
About
Founded
2014
Website
Employees
2
